Balaxi sets up its own on-ground infrastructure in each market—this includes hiring local medical representatives, setting up warehouses, and building strong distribution channels. This is very rare among Indian mid-cap pharma companies and is more common with large multinational corporations. Once Balaxi registers a product in a country, that registration typically lasts 5–10 years, and sometimes even longer. This acts as a moat because competitors must go through lengthy regulatory and bureaucratic processes to enter the same market with the same molecule.